Putnam Hartford Capital Manager

Putnam Global Health Care Subaccount

The subaccount seeks capital appreciation.

Fund description

The subaccount seeks to capitalize on the strength of the health-care sector, targeting companies of all sizes. Holdings encompass an array of industries, including pharmaceuticals, health-care services, and biotechnology. The fund seeks companies that offer strong long-term growth prospects, regardless of their size.

Sales story

Investing in the health-care sectorA dynamic sector: From biotech to pharmaceuticals, the fund seeks out companies that profit from the global demand for health care.A range of companies: The fund invests worldwide in businesses at different stages of growth, from rapidly growing newer companies to established global corporations.Actively managed: Unlike passively managed ETFs, Putnam global sector funds combine rigorous fundamental research and disciplined quantitative analysis with macroeconomic views.

Management team

Risk Characteristics as of 08/31/17

Alpha (%) -0.74
Beta 1.09
R squared 0.93
Standard deviation (3 yrs.) 13.39

The fund concentrates its investments in one region or in one sector and involves more risk than a fund that invests more broadly. Variable annuities are long-term investments designed for retirement purposes. Withdrawals prior to age 59 1/2 may be subject to a 10% IRS penalty.

Growth investing targets companies with above-average earnings that may be subject to price volatility if earnings expectations are not met.

‡ Lipper is an industry research firm whose rankings are based on total return performance, vary over time, and do not reflect the effects of sales charges. Past performance is not indicative of future results.

Quick facts as of 08/31/17

Fiscal Year End December
Asset Class Putnam Hartford Capital Manager
Subaccount Status Open to new investors
Number of issues 56
Turnover (fiscal year end) 24%
Net Assets $151M
Inception Date 05/01/98

Holdings

Top 10 holdings as of 08/31/17

UnitedHealth Group 5.49%
Amgen 4.84%
Becton Dickinson And 4.84%
Jazz Pharmaceuticals 4.75%
Novartis Ag 4.30%
Bayer Ag 4.04%
Danaher Corp 3.96%
Johnson & Johnson 3.95%
Biogen 3.77%
Celgene Corp 3.55%
Top 10 holdings, total: 43.49%

Equity Holdings as of 06/30/17

AMGEN INC 5.88%
MERCK & CO. INC. 5.55%
UNITEDHEALTH GROUP INC 5.09%
JAZZ PHARMACEUTICALS PLC 4.92%
BECTON DICKINSON AND CO 4.71%
NOVARTIS AG-REG 4.21%
BAYER AG-REG 4.06%
JOHNSON & JOHNSON 3.93%
BIOGEN INC 3.72%
SANOFI 3.46%
DANAHER CORP 3.41%
CELGENE CORP 3.30%
ASTRAZENECA PLC 2.87%
ROCHE HOLDING AG-GENUSSCHEIN 2.85%
BOSTON SCIENTIFIC CORP 2.61%
MCKESSON CORP 2.27%
PFIZER INC 2.25%
SHIRE PLC 2.14%
AGILENT TECHNOLOGIES INC 1.92%
GILEAD SCIENCES INC 1.91%
REGENERON PHARMACEUTICALS 1.88%
DENTSPLY SIRONA INC 1.54%
INTUITIVE SURGICAL INC 1.54%
BRISTOL-MYERS SQUIBB CO 1.49%
HUMANA INC 1.44%
CLOVIS ONCOLOGY INC 1.31%
GLAXOSMITHKLINE PLC 1.30%
CHUGAI PHARMACEUTICAL CO LTD 1.29%
SHIONOGI & CO LTD 1.07%
PACIRA PHARMACEUTICALS INC 1.06%
MEDICINES COMPANY 0.98%
WALGREENS BOOTS ALLIANCE INC 0.94%
BIO-RAD LABORATORIES-A 0.83%
BIOVERATIV INC 0.79%
GRIFOLS SA-ADR 0.70%
CLINIGEN GROUP PLC 0.69%
STERICYCLE INC 0.66%
PENUMBRA INC 0.63%
AIN HOLDINGS INC 0.58%
ACLARIS THERAPEUTICS INC 0.57%
NIPPON SHINYAKU CO LTD 0.51%
ILLUMINA INC 0.50%
FRESENIUS MEDICAL CARE AG & 0.46%
CHINA BIOLOGIC PRODUCTS INC 0.45%
NEUROCRINE BIOSCIENCES INC 0.42%
AUROBINDO PHARMA LTD 0.38%
ASPEN PHARMACARE HOLDINGS LT 0.34%
ARRAY BIOPHARMA INC 0.22%
OVID THERAPEUTICS INC - RESTRICTED 0.22%
TESARO INC 0.15%
SINOPHARM GROUP CO-H 0.09%
HTG MOLECULAR DIAGNOSTICS 0.01%
NEURALSTEM INC SERIES K COMMON STOCK PURCHASE WARRANT 0.00%

Full Portfolio Holdings as of 06/30/17

AMGEN INC 5.88%
MERCK & CO. INC. 5.55%
UNITEDHEALTH GROUP INC 5.09%
JAZZ PHARMACEUTICALS PLC 4.92%
BECTON DICKINSON AND CO 4.71%
NOVARTIS AG-REG 4.21%
BAYER AG-REG 4.06%
JOHNSON & JOHNSON 3.93%
BIOGEN INC 3.72%
SANOFI 3.46%
DANAHER CORP 3.41%
CELGENE CORP 3.30%
ASTRAZENECA PLC 2.87%
ROCHE HOLDING AG-GENUSSCHEIN 2.85%
BOSTON SCIENTIFIC CORP 2.61%
MCKESSON CORP 2.27%
PFIZER INC 2.25%
SHIRE PLC 2.14%
AGILENT TECHNOLOGIES INC 1.92%
GILEAD SCIENCES INC 1.91%
REGENERON PHARMACEUTICALS 1.88%
DENTSPLY SIRONA INC 1.54%
INTUITIVE SURGICAL INC 1.54%
BRISTOL-MYERS SQUIBB CO 1.49%
HUMANA INC 1.44%
CLOVIS ONCOLOGY INC 1.31%
GLAXOSMITHKLINE PLC 1.30%
CHUGAI PHARMACEUTICAL CO LTD 1.29%
SHIONOGI & CO LTD 1.07%
PACIRA PHARMACEUTICALS INC 1.06%
MEDICINES COMPANY 0.98%
WALGREENS BOOTS ALLIANCE INC 0.94%
BIO-RAD LABORATORIES-A 0.83%
BIOVERATIV INC 0.79%
GRIFOLS SA-ADR 0.70%
CLINIGEN GROUP PLC 0.69%
STERICYCLE INC 0.66%
PENUMBRA INC 0.63%
AIN HOLDINGS INC 0.58%
ACLARIS THERAPEUTICS INC 0.57%
NIPPON SHINYAKU CO LTD 0.51%
ILLUMINA INC 0.50%
FRESENIUS MEDICAL CARE AG & 0.46%
CHINA BIOLOGIC PRODUCTS INC 0.45%
NEUROCRINE BIOSCIENCES INC 0.42%
AUROBINDO PHARMA LTD 0.38%
ASPEN PHARMACARE HOLDINGS LT 0.34%
NEUROCRINE P/P 144A CV 02.2500 05/15/2024 0.26%
ARRAY BIOPHARMA INC 0.22%
OVID THERAPEUTICS INC - RESTRICTED 0.22%
TESARO INC 0.15%
SINOPHARM GROUP CO-H 0.09%
EUR/USD 09/20/2017 BANKAM 0.02%
CHF/USD 09/20/2017 JPMCB 0.01%
DKK/USD 09/20/2017 CITI 0.01%
HTG MOLECULAR DIAGNOSTICS 0.01%
JPY/USD 08/16/2017 CSI-FX 0.01%
AUD/USD 07/19/2017 HSBCB 0.00%
INDIAN RUPEE CALL ACCOUNT 0.00%
JAPANESE YEN CALL ACCOUNT 0.00%
NEURALSTEM INC SERIES K COMMON STOCK PURCHASE WARRANT 0.00%
POUND STERLING CALL ACCOUNT 0.00%

Prior top 10 holdings

Top 10 holdings as of 08/31/17
1: UnitedHealth Group 5.49%
2: Amgen 4.84%
3: Becton Dickinson And 4.84%
4: Jazz Pharmaceuticals 4.75%
5: Novartis Ag 4.30%
6: Bayer Ag 4.04%
7: Danaher Corp 3.96%
8: Johnson & Johnson 3.95%
9: Biogen 3.77%
10: Celgene Corp 3.55%
Holdings represent 43.49% of portfolio
Top 10 holdings as of 07/31/17
1: UnitedHealth Group 5.30%
2: Becton Dickinson And 4.90%
3: Jazz Pharmaceuticals 4.89%
4: Amgen 4.76%
5: Novartis Ag 4.34%
6: Bayer Ag 4.01%
7: Biogen 3.99%
8: Johnson & Johnson 3.96%
9: Danaher Corp 3.87%
10: Sanofi 3.47%
Holdings represent 43.49% of portfolio
Top 10 holdings as of 06/30/17
1: Amgen 5.88%
2: Merck 5.55%
3: UnitedHealth Group 5.09%
4: Jazz Pharmaceuticals 4.92%
5: Becton Dickinson And 4.71%
6: Novartis Ag 4.21%
7: Bayer Ag 4.06%
8: Johnson & Johnson 3.93%
9: Biogen 3.72%
10: Sanofi 3.46%
Holdings represent 45.53% of portfolio
Top 10 holdings as of 05/31/17
1: Merck 5.77%
2: Amgen 5.42%
3: Celgene Corp 4.80%
4: Becton Dickinson And 4.68%
5: Bayer Ag 4.27%
6: Novartis Ag 4.24%
7: Jazz Pharmaceuticals 4.08%
8: Johnson & Johnson 3.90%
9: UnitedHealth Group 3.78%
10: Sanofi 3.66%
Holdings represent 44.60% of portfolio

Portfolio Composition as of 08/31/17

Common stock 98.49%
Cash and net other assets 1.22%
Convertible bonds 0.29%

Portfolio allocations vary over time. The fund concentrates its investments in one region or in one sector and involves more risk than a fund that invests more broadly. Variable annuities are long-term investments designed for retirement purposes. Withdrawals prior to age 59 1/2 may be subject to a 10% IRS penalty.

Growth investing targets companies with above-average earnings that may be subject to price volatility if earnings expectations are not met.

Lipper is an industry research firm whose rankings are based on total return performance, vary over time, and do not reflect the effects of sales charges. Past performance is not indicative of future results.

Top Industry Sectors as of 08/31/17

Pharmaceuticals 40.88%
Biotechnology 26.48%
Health Care Equipment & Supplies 16.40%
Health Care Providers & Services 9.20%
Life Sciences Tools & Services 3.79%
Food & Staples Retailing 1.76%
Cash and net other assets 1.22%
Diversified Financial Services 0.26%
Health Care Technology 0.01%

Country Allocation as of 08/31/17

United States 71.06%
Switzerland 7.33%
United Kingdom 6.58%
Germany 4.49%
Japan 3.59%
France 3.53%
Cash and net other assets 1.22%
Spain 0.69%
China 0.49%
 
Other
1.02%
India 0.41%
South Africa 0.35%
Ireland 0.26%